Pharmaceutical formulations

A preparation and active agent technology, applied in the field of pharmaceutical preparations, can solve the problems affecting the robustness of preparations and the impact of preparation robustness

Inactive Publication Date: 2010-03-24
ABBOTT LAB INC +1
View PDF11 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Second, the percentage of fenofibrate salt in the formulation also affects the robustness of the formulation
Fin

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical formulations
  • Pharmaceutical formulations
  • Pharmaceutical formulations

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0095] Tablet preparation:

[0096] Add the ingredients in the granule to the granulator (or mixer), dry mix, then gradually add an appropriate amount of water to the granulator, and granulate until the best granules are obtained. The granules are then wet aggregated for an additional period, if necessary, before being dried in an oven or fluid bed dryer. The dried granules were processed using a fitzmill or manually sieved using a sieve. Sift the silica and HPC Exf through a 40 mesh screen. The ground granules, sieved silica and HPC were charged into a V-blender and mixed at -26 rpm for 5 minutes. Sieve the SSF through a 40-mesh sieve. The screened SSF was added to the mixer and mixed for an additional 5 minutes. The granules were weighed and compressed into tablets using a rounder tooling with a target weight of 275 mg / tablet. The target sheet hardness is -20 SCU.

Embodiment 2

[0098] Solubility determination:

[0099] The solubility value of fenofibrate salt in water was determined at 25°C. These salts were weighed, placed in glass vials, and water was added. In a 25 °C water bath, swirl the suspension head to tail for about 2 days. Measure the pH of the suspension. Residual solids were then removed by filtration through a 0.45 μm PTFE membrane filter. The resulting saturated solution was suitably diluted into the HPLC mobile phase and analyzed by the HPLC assay described below (Table 3). At the end of the experiment, the powder x-ray diffraction pattern of the collected residual solid was recorded.

[0100] HPLC analysis:

[0101] table 3

[0102] HPLC Analysis of Fenofibric Acid

[0103]

[0104]

Embodiment 3

[0106] Intrinsic Dissolution Rate (IDR):

[0107] The IDR of fenofibrate salt was determined in 50 mM sodium citrate buffer, pH 4.0 or pH 6.8 (NaCl, μ = 0.155M).

[0108] Small tablets of these salts were prepared by compressing approximately 100 mg of the compound in a stainless steel mold at 1300 lbs force with a residence time of 1 minute. The mold containing the tablet was submerged in 400 mL of dissolution medium at 37°C. The solution was stirred with a paddle at -60 rpm. At each time point, 3 mL samples were taken and filtered. The first half of the filtrate was discarded and the residue collected and assayed by the HPLC method described above. The total volume of dissolution medium was kept constant by replenishing lost volume at each data point with fresh buffer at 37°C.

[0109] Table 4

[0110] Salt

Solubility

(mg / ml)

IDR ＊

at 8 hours

% of 0.05M

at 8 hours

% of 0.3M

in 8 hours

time difference

C...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Solubilityaaaaaaaaaa
Hardnessaaaaaaaaaa
Login to view more

Abstract

The present invention provides a modified release formulation comprising an active agent in a hydrophilic polymer matrix wherein the active agent is a salt of fenofibric acid wherein the release rateof the formulation in an in vitro dissolution is substantially independent of the ionic strength of the dissolution media.

Description

[0001] Related application information [0002] This application claims priority to US Application Serial No. 60 / 829,255, filed October 12, 2006, the contents of which are incorporated herein by reference. [0003] This application is a continuation-in-part of U.S. Application Serial No. 11 / 548,960, filed October 12, 2006, which is a continuation-in-part of U.S. Application Serial No. 11 / 399,964, filed April 7, 2006 , US Application No. 11 / 399,964 claims priority to US Application No. 60 / 669,699, filed April 8, 2005, the contents of each of which are incorporated herein by reference. [0004] This application is a continuation-in-part of U.S. Application Serial No. 11 / 548,982, filed October 12, 2006, which is a continuation-in-part of U.S. Application Serial No. 11 / 399,983, filed April 7, 2006 , US Application No. 11 / 399,983 claims priority to US Application No. 60 / 669,699, filed April 8, 2005, the contents of each of which are incorporated herein by reference. [0005] This ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/192A61K9/20A61K9/28A61K9/16
CPCA61K9/1652A61K9/2054A61K31/192A61K9/2018A61K9/2846A61K9/1623A61P3/06A61K9/28A61K9/20A61K47/38
Inventor Y·高R·J·楚奇D·Y·李N·源H·吴
Owner ABBOTT LAB INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap